SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-021644
Filing Date
2023-02-14
Accepted
2023-02-14 16:17:11
Documents
17
Period of Report
2023-02-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm236637d1_8k.htm   iXBRL 8-K 38680
2 EXHIBIT 99.1 tm236637d1_ex99-1.htm EX-99.1 14002
7 GRAPHIC tm236637d1_ex99-1img001.jpg GRAPHIC 282340
8 GRAPHIC tm236637d1_ex99-1img002.jpg GRAPHIC 280501
9 GRAPHIC tm236637d1_ex99-1img003.jpg GRAPHIC 236709
  Complete submission text file 0001104659-23-021644.txt   1397592

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmgm-20230214.xsd EX-101.SCH 4070
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgm-20230214_def.xml EX-101.DEF 27972
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgm-20230214_lab.xml EX-101.LAB 39560
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgm-20230214_pre.xml EX-101.PRE 26590
11 EXTRACTED XBRL INSTANCE DOCUMENT tm236637d1_8k_htm.xml XML 7157
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 23629586
SIC: 2834 Pharmaceutical Preparations